Synopsis
Synopsis
0
VMF
0
Australia
0
South Africa
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 5-chloro-4-(2-imidazolin-2-yl-amino)-2,1,3-benzothiadiazole
2. Ds 103-282
3. Sirdalud
4. Tizanidine
5. Tizanidine Monohydrochloride
6. Zanaflex
1. Tizanidine Hcl
2. 64461-82-1
3. Zanaflex
4. Tizanidine (hydrochloride)
5. 5-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine Hydrochloride
6. Ds 103-282
7. An021
8. 5-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)benzo[c][1,2,5]thiadiazol-4-amine Hydrochloride
9. B53e3nmy5c
10. Tizanidine (as Hydrochloride)
11. 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole Monohydrochloride
12. 5-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine;hydrochloride
13. Ds-103-282
14. 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole Hydrochloride
15. An-021
16. 64461-82-1 (hcl)
17. 2,1,3-benzothiadiazol-4-amine, 5-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-, Monohydrochloride
18. 5-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-2,1,3-benzothiadiazole-4-amine Hydrochloride
19. Smr000499584
20. Unii-b53e3nmy5c
21. Sr-01000765392
22. Tizanidine * Hcl
23. Zanaflex (tn)
24. Mfcd00798231
25. Tizanidine Hydrochloride [usan:usp:jan]
26. 5-iodoisoquinolin-8-ol
27. Schembl41199
28. Mls001076686
29. Mls001306412
30. Mls001333593
31. Chebi:9609
32. Tizanidine Hydrochloride- Bio-x
33. Chembl1200329
34. Dtxsid9046990
35. Ds-103282 Ch
36. Hy-b0194a
37. An-021a
38. Nvd-422
39. Amy18121
40. Bcp28540
41. Tox21_501114
42. S1437
43. Tizanidine Hydrochloride [mi]
44. Tizanidine Hydrochloride (jp17/usp)
45. Tizanidine Hydrochloride [jan]
46. Akos005267234
47. Brn0618691
48. Ccg-220602
49. Ccg-222418
50. Ks-1120
51. Lp01114
52. Nc00654
53. Tizanidine Hydrochloride [usan]
54. Tizanidine Hydrochloride [mart.]
55. Tizanidine Hydrochloride [vandf]
56. Ncgc00261799-01
57. Tizanidine Hydrochloride [who-dd]
58. Ac-22546
59. Bt164478
60. Db-011661
61. Ds-103282
62. Ds103-282
63. Ft-0656022
64. Sw199068-2
65. T2527
66. En300-49853
67. Tizanidine Hydrochloride [orange Book]
68. D00776
69. D70434
70. Tizanidine Hydrochloride [ep Monograph]
71. Tizanidine Hydrochloride [usp Impurity]
72. Tizanidine Hydrochloride [usp Monograph]
73. Tizanidine Hydrochloride, >=98% (hplc), Powder
74. Sr-01000765392-4
75. Q27274381
76. Tizanidine Hydrochloride 100 Microg/ml In Acetonitrile
77. 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazolehydrochloride
78. Tizanidine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
79. (5-chloro-2,1,3-benzothiadiazol-4-yl)-(4,5-dihydro-1h-imidazol-2-yl)azanium;chloride
80. 5-(chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine Hydrochloride
81. 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole Monohydrochloride.
82. 5-chloro-4-[(4,5-dihydro-1h-imidazol-2-yl)amino]-2,1,3-benzothiadiazole Hydrochloride
83. 5-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-2,1,3benzothiadiazole-4-amine Hydrochloride
84. 5-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)benzo[c][1,2,5]thiadiazol-4-aminehydrochloride
85. Tizanidine Hydrochloride, 500 Mug/ml In Methanol, Certified Reference Material
86. Tizanidine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
Molecular Weight | 290.17 g/mol |
---|---|
Molecular Formula | C9H9Cl2N5S |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 2 |
Exact Mass | 288.9955719 g/mol |
Monoisotopic Mass | 288.9955719 g/mol |
Topological Polar Surface Area | 90.4 Ų |
Heavy Atom Count | 17 |
Formal Charge | 0 |
Complexity | 300 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Tizanidine hydrochloride |
PubMed Health | Tizanidine (By mouth) |
Drug Classes | Skeletal Muscle Relaxant, Centrally Acting |
Drug Label | Zanaflex (tizanidine hydrochloride) is a centrally acting 2-adrenergic agonist. Tizanidine HCl (tizanidine) is a white to off-white, fine crystalline powder, which is odorless or with a faint characteristic odor. Tizanidine is slightly soluble in... |
Active Ingredient | Tizanidine hydrochloride |
Dosage Form | Tablet; Capsule |
Route | Oral |
Strength | eq 4mg base; eq 2mg base; eq 6mg base |
Market Status | Prescription |
Company | Corepharma; Mylan Pharms; Teva; Apotex; Sun Pharm Inds; Prosam Labs; Sandoz; Dr Reddys Labs; Mylan; Unichem Labs |
2 of 4 | |
---|---|
Drug Name | Zanaflex |
Drug Label | Zanaflex (tizanidine hydrochloride) is a centrally acting 2-adrenergic agonist. Tizanidine HCl (tizanidine) is a white to off-white, fine crystalline powder, which is odorless or with a faint characteristic odor. Tizanidine is slightly soluble in... |
Active Ingredient | Tizanidine hydrochloride |
Dosage Form | Tablet; Capsule |
Route | Oral |
Strength | eq 4mg base; eq 2mg base; eq 6mg base |
Market Status | Prescription |
Company | Acorda |
3 of 4 | |
---|---|
Drug Name | Tizanidine hydrochloride |
PubMed Health | Tizanidine (By mouth) |
Drug Classes | Skeletal Muscle Relaxant, Centrally Acting |
Drug Label | Zanaflex (tizanidine hydrochloride) is a centrally acting 2-adrenergic agonist. Tizanidine HCl (tizanidine) is a white to off-white, fine crystalline powder, which is odorless or with a faint characteristic odor. Tizanidine is slightly soluble in... |
Active Ingredient | Tizanidine hydrochloride |
Dosage Form | Tablet; Capsule |
Route | Oral |
Strength | eq 4mg base; eq 2mg base; eq 6mg base |
Market Status | Prescription |
Company | Corepharma; Mylan Pharms; Teva; Apotex; Sun Pharm Inds; Prosam Labs; Sandoz; Dr Reddys Labs; Mylan; Unichem Labs |
4 of 4 | |
---|---|
Drug Name | Zanaflex |
Drug Label | Zanaflex (tizanidine hydrochloride) is a centrally acting 2-adrenergic agonist. Tizanidine HCl (tizanidine) is a white to off-white, fine crystalline powder, which is odorless or with a faint characteristic odor. Tizanidine is slightly soluble in... |
Active Ingredient | Tizanidine hydrochloride |
Dosage Form | Tablet; Capsule |
Route | Oral |
Strength | eq 4mg base; eq 2mg base; eq 6mg base |
Market Status | Prescription |
Company | Acorda |
Muscle Relaxants, Central
A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
Analgesics
Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)
Anticonvulsants
Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)
Adrenergic alpha-2 Receptor Agonists
Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Agonists.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
68
PharmaCompass offers a list of Tizanidine HCl API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tizanidine HCl manufacturer or Tizanidine HCl supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tizanidine HCl manufacturer or Tizanidine HCl supplier.
PharmaCompass also assists you with knowing the Tizanidine HCl API Price utilized in the formulation of products. Tizanidine HCl API Price is not always fixed or binding as the Tizanidine HCl Price is obtained through a variety of data sources. The Tizanidine HCl Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Zanaflex;Sirdalud manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zanaflex;Sirdalud, including repackagers and relabelers. The FDA regulates Zanaflex;Sirdalud manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zanaflex;Sirdalud API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Zanaflex;Sirdalud manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Zanaflex;Sirdalud supplier is an individual or a company that provides Zanaflex;Sirdalud active pharmaceutical ingredient (API) or Zanaflex;Sirdalud finished formulations upon request. The Zanaflex;Sirdalud suppliers may include Zanaflex;Sirdalud API manufacturers, exporters, distributors and traders.
click here to find a list of Zanaflex;Sirdalud suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Zanaflex;Sirdalud DMF (Drug Master File) is a document detailing the whole manufacturing process of Zanaflex;Sirdalud active pharmaceutical ingredient (API) in detail. Different forms of Zanaflex;Sirdalud DMFs exist exist since differing nations have different regulations, such as Zanaflex;Sirdalud USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Zanaflex;Sirdalud DMF submitted to regulatory agencies in the US is known as a USDMF. Zanaflex;Sirdalud USDMF includes data on Zanaflex;Sirdalud's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Zanaflex;Sirdalud USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Zanaflex;Sirdalud suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Zanaflex;Sirdalud Drug Master File in Japan (Zanaflex;Sirdalud JDMF) empowers Zanaflex;Sirdalud API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Zanaflex;Sirdalud JDMF during the approval evaluation for pharmaceutical products. At the time of Zanaflex;Sirdalud JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Zanaflex;Sirdalud suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Zanaflex;Sirdalud Drug Master File in Korea (Zanaflex;Sirdalud KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Zanaflex;Sirdalud. The MFDS reviews the Zanaflex;Sirdalud KDMF as part of the drug registration process and uses the information provided in the Zanaflex;Sirdalud KDMF to evaluate the safety and efficacy of the drug.
After submitting a Zanaflex;Sirdalud KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Zanaflex;Sirdalud API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Zanaflex;Sirdalud suppliers with KDMF on PharmaCompass.
A Zanaflex;Sirdalud CEP of the European Pharmacopoeia monograph is often referred to as a Zanaflex;Sirdalud Certificate of Suitability (COS). The purpose of a Zanaflex;Sirdalud CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Zanaflex;Sirdalud EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Zanaflex;Sirdalud to their clients by showing that a Zanaflex;Sirdalud CEP has been issued for it. The manufacturer submits a Zanaflex;Sirdalud CEP (COS) as part of the market authorization procedure, and it takes on the role of a Zanaflex;Sirdalud CEP holder for the record. Additionally, the data presented in the Zanaflex;Sirdalud CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Zanaflex;Sirdalud DMF.
A Zanaflex;Sirdalud CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Zanaflex;Sirdalud CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Zanaflex;Sirdalud suppliers with CEP (COS) on PharmaCompass.
A Zanaflex;Sirdalud written confirmation (Zanaflex;Sirdalud WC) is an official document issued by a regulatory agency to a Zanaflex;Sirdalud manufacturer, verifying that the manufacturing facility of a Zanaflex;Sirdalud active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Zanaflex;Sirdalud APIs or Zanaflex;Sirdalud finished pharmaceutical products to another nation, regulatory agencies frequently require a Zanaflex;Sirdalud WC (written confirmation) as part of the regulatory process.
click here to find a list of Zanaflex;Sirdalud suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Zanaflex;Sirdalud as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Zanaflex;Sirdalud API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Zanaflex;Sirdalud as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Zanaflex;Sirdalud and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Zanaflex;Sirdalud NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Zanaflex;Sirdalud suppliers with NDC on PharmaCompass.
Zanaflex;Sirdalud Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Zanaflex;Sirdalud GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Zanaflex;Sirdalud GMP manufacturer or Zanaflex;Sirdalud GMP API supplier for your needs.
A Zanaflex;Sirdalud CoA (Certificate of Analysis) is a formal document that attests to Zanaflex;Sirdalud's compliance with Zanaflex;Sirdalud specifications and serves as a tool for batch-level quality control.
Zanaflex;Sirdalud CoA mostly includes findings from lab analyses of a specific batch. For each Zanaflex;Sirdalud CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Zanaflex;Sirdalud may be tested according to a variety of international standards, such as European Pharmacopoeia (Zanaflex;Sirdalud EP), Zanaflex;Sirdalud JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Zanaflex;Sirdalud USP).